Ahmadi-Hadad, Armia
De Rosa, Egle
Di Serafino, Luigi http://orcid.org/0000-0002-6324-8527
Esposito, Giovanni
Funding for this research was provided by:
Università degli Studi di Napoli Federico II
Article History
Received: 6 June 2024
Accepted: 23 July 2024
First Online: 6 August 2024
Declarations
:
: Dr. Di Serafino reports personal fees from Abbott Vascular and Hexacath, outside the submitted work. Prof. Esposito reports personal fees from Abbott Vascular, Amgen, Boehringer Ingelheim, Edwards Lifesciences, Terumo, and Sanofi, outside the submitted work and research grants to the institution from Alvimedica, Boston Scientific, and Medtronic. Armia Ahmadi-Hadad and Egle De Rosa have no conflicts of interest to declare.